Does disease-irrelevant intrathecal synthesis in multiple sclerosis make sense in the light of tertiary lymphoid organs?

Frontiers in Neurology

Volumn 5 MAR, Issue , 2014, Pages

  Bonnan, Mickael ^a  

^a CENTRE HOSPITALIER DE PAU   (France)

Author keywords

Antibody response; Cerebrospinal fluid; Epstein Barr virus; Lymphoid tissue; Multiple sclerosis

Indexed keywords

AZATHIOPRINE; IMMUNOGLOBULIN G; MITOXANTRONE; NATALIZUMAB; OLIGOCLONAL BAND; RITUXIMAB; RUBELLA ANTIBODY; STROMAL CELL DERIVED FACTOR 1;

ADRENOLEUKODYSTROPHY; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; EPSTEIN BARR VIRUS INFECTION; GENETIC DISORDER; HERPES ZOSTER ENCEPHALITIS; HUMAN; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; LYME DISEASE; LYMPHOID ORGAN; MIXED INFECTION; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; PLASMA CELL; SEROPREVALENCE; TERTIARY LYMPHOID ORGAN;

EID: 84898032563     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2014.00027     Document Type: Article

References (93)

1. Bonnan M. Intrathecal immune reset in multiple sclerosis: exploring a new concept. Med Hypotheses (2013) 82:300-9. doi: 10.1016/j.mehy.2013.12.015
2. Gredler V, Reindl M. B cells accumulate in the cerebrospinal fluid in inflammatory neurological diseases. J Cytol Histol (2012) S1(001):1-7. doi:10.1016/j.neulet.2010.10.036
3. Beyer NH, Lueking A, Kowald A, Frederiksen JL, Heegaard NH. Investigation of autoantibody profiles for cerebrospinal fluid biomarker discovery in patients with relapsing-remitting multiple sclerosis. J Neuroimmunol (2012) 242(1-2):26-32. doi:10.1016/j.jneuroim.2011.08.013
4. Libbey JE, McCoy LL, Fujinami RS. Molecular mimicry in multiple sclerosis. Int Rev Neurobiol (2007) 79:127-47. doi:10.1016/S0074-7742(07)79006-2
5. Kuenzle S, von Budingen HC, Meier M, Harrer MD, Urich E, Becher B, et al. Pathogen specificity and autoimmunity are distinct features of antigen-driven immune responses in neuroborreliosis. Infect Immun (2007) 75(8):3842-7. doi:10.1128/IAI.00260-07
6. Robinson-Agramonte M, Reiber H, Cabrera-Gomez JA, Galvizu R. Intrathecal polyspecific immune response to neurotropic viruses in multiple sclerosis: a comparative report from Cuban patients. Acta Neurol Scand (2007) 115(5):312-8. doi:10.1111/j.1600-0404.2006.00755.x
7. Magliozzi R, Howell OW, Reeves C, Roncaroli F, Nicholas R, Serafini B, et al. A gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol (2010) 68(4):477-93. doi:10.1002/ana.22230
8. Reiber H, Ungefehr S, Jacobi C. The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler (1998) 4(3):111-7. doi:10.1191/135245898678909448
9. Rostasy K, Reiber H, Pohl D, Lange P, Ohlenbusch A, Eiffert H, et al. Chlamydia pneumoniae in children with MS: frequency and quantity of intrathecal antibodies. Neurology (2003) 61(1):125-8. doi:10.1212/01.WNL.0000070782.27949.F7
10. Reiber H. Cerebrospinal fluid - physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler (1998) 4(3):99-107. doi:10.1191/135245898678909439
11. Derfuss T, Gurkov R, Then Bergh F, Goebels N, Hartmann M, Barz C, et al. Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response. Brain (2001) 124(Pt 7):1325-35. doi:10.1093/brain/124.7.1325
12. Franciotta D, Di Stefano AL, Jarius S, Zardini E, Tavazzi E, Ballerini C, et al. Cerebrospinal BAFF and Epstein-Barr virus-specific oligoclonal bands in multiple sclerosis and other inflammatory demyelinating neurological diseases. J Neuroimmunol (2011) 230(1-2):160-3. doi:10.1016/j.jneuroim.2010.10.027
13. Owens GP, Burgoon MP, Devlin ME, Gilden DH. Extraction and purification of active IgG from SSPE and MS brain. J Virol Methods (1997) 68(2):119-25. doi:10.1016/S0166-0934(97)00118-3
14. Brettschneider J, Tumani H, Kiechle U, Muche R, Richards G, Lehmensiek V, et al. IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome. PLoS One (2009) 4(11):e7638. doi:10.1371/journal.pone.0007638
15. Brecht I, Weissbrich B, Braun J, Toyka KV, Weishaupt A, Buttmann M. Intrathecal, polyspecific antiviral immune response in oligoclonal band negative multiple sclerosis. PLoS One (2012) 7(7):e40431. doi:10.1371/journal.pone.0040431
16. Jarius S, Franciotta D, Bergamaschi R, Rauer S, Wandinger KP, Petereit HF, et al. Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica. J Neurol Neurosurg Psychiatry (2008) 79(10):1134-6. doi:10.1136/jnnp.2007.133330
17. Rosche B, Laurent S, Conradi S, Hofmann J, Ruprecht K, Harms L. Measles IgG antibody index correlates with T2 lesion load on MRI in patients with early multiple sclerosis. PLoS One (2012) 7(1):e28094. doi:10.1371/journal.pone.0028094
18. Ahlgren C, Oden A, Bergstrom T, Lycke J. Serum and CSF measles antibody levels increase over time in patients with multiple sclerosis or clinically isolated syndrome. J Neuroimmunol (2012) 247(1-2):70-4. doi:10.1016/j.jneuroim.2012.03.014
19. Ahlgren C, Oden A, Haghighi S, Andersen O, Bergstrom T, Lycke J. The effect of live, attenuated measles vaccine and measles infection on measles antibody levels in serum and CSF of patients with multiple sclerosis or clinically isolated syndrome. J Neuroimmunol (2011) 235(1-2):98-103. doi:10.1016/j.jneuroim.2011.04.002
20. Fainardi E, Castellazzi M, Tamborino C, Seraceni S, Tola MR, Granieri E, et al. Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms. J Neurovirol (2009) 15(5-6):425-33. doi:10.3109/13550280903475580
21. Sandberg-Wollheim M, Vandvik B, Nadj C, Norrby E. The intrathecal immune response in the early stage of multiple sclerosis. J Neurol Sci (1987) 81(1):45-53. doi:10.1016/0022-510X(87)90182-1
22. Fainardi E, Castellazzi M, Casetta I, Cultrera R, Vaghi L, Granieri E, et al. Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms. J Neurol Sci (2004) 217(2):181-8. doi:10.1016/j.jns.2003.09.012
23. Krametter D, Niederwieser G, Berghold A, Birnbaum G, Strasser-Fuchs S, Hartung HP, et al. Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker. Mult Scler (2001) 7(1):13-8. doi:10.1191/135245801676514804
24. Yao SY, Stratton CW, Mitchell WM, Sriram S. CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens. Neurology (2001) 56(9):1168-76. doi:10.1212/WNL.56.9.1168
25. Franciotta D, Zardini E, Bergamaschi R, Grimaldi LM, Andreoni L, Cosi V. Analysis of Chlamydia pneumoniae-specific oligoclonal bands in multiple sclerosis and other neurologic diseases. Acta Neurol Scand (2005) 112(4):238-41. doi:10.1111/j.1600-0404.2005.00407.x
26. Derfuss T, Hohlfeld R, Meinl E. Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B-cell response. J Neurol (2005) 252(8):968-71. doi:10.1007/s00415-005-0794-z
27. Virtanen JO, Pietilainen-Nicklen J, Uotila L, Farkkila M, Vaheri A, Koskiniemi M. Intrathecal human herpesvirus 6 antibodies in multiple sclerosis and other demyelinating diseases presenting as oligoclonal bands in cerebrospinal fluid. J Neuroimmunol (2011) 237(1-2):93-7. doi:10.1016/j.jneuroim.2011.06.012
28. Bednárová J, Stourac P, Adam P. Relevance of immunological variables in neuroborreliosis and multiple sclerosis. Acta Neurol Scand (2005) 112(2):97-102. doi:10.1111/j.1600-0404.2005.00418.x
29. Felgenhauer K, Schadlich HJ, Nekic M, Ackermann R. Cerebrospinal fluid virus antibodies. A diagnostic indicator for multiple sclerosis? J Neurol Sci (1985) 71(2-3):291-9. doi:10.1016/0022-510X(85)90067-X
30. Woyciechowska JL, Dambrozia J, Leinikki P, Shekarchi C, Wallen W, Sever J, et al. Viral antibodies in twins with multiple sclerosis. Neurology (1985) 35(8):1176-80. doi:10.1212/WNL.35.8.1176
31. Thompson JA, Bray PF, Glasgow LA. Multiple sclerosis and elevation of cerebrospinal fluid vaccinia virus antibody. Neurology (1975) 25(1):94-6. doi:10.1212/WNL.25.1.94
32. Chu VT, Berek C. The establishment of the plasma cell survival niche in the bone marrow. Immunol Rev (2013) 251(1):177-88. doi:10.1111/imr.12011
33. Eriksson K, Quiding-Jarbrink M, Osek J, Moller A, Bjork S, Holmgren J, et al. Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination. Infect Immun (1998) 66(12):5889-96.
34. Manz RA, Hauser AE, Hiepe F, Radbruch A. Maintenance of serum antibody levels. Annu Rev Immunol (2005) 23:367-86. doi:10.1146/annurev.immunol.23.021704.115723
35. Cao Y, Gordic M, Kobold S, Lajmi N, Meyer S, Bartels K, et al. An optimized assay for the enumeration of antigen-specific memory B cells in different compartments of the human body. J Immunol Methods (2010) 358(1-2):56-65. doi:10.1016/j.jim.2010.03.009
36. Withers DR, Fiorini C, Fischer RT, Ettinger R, Lipsky PE, Grammer AC. T cell-dependent survival of CD20+ and CD20- plasma cells in human secondary lymphoid tissue. Blood (2007) 109(11):4856-64. doi:10.1182/blood-2006-08-043414
37. Thaunat O, Patey N, Caligiuri G, Gautreau C, Mamani-Matsuda M, Mekki Y, et al. Chronic rejection triggers the development of an aggressive intragraft immune response through recapitulation of lymphoid organogenesis. J Immunol (2010) 185(1):717-28. doi:10.4049/jimmunol.0903589
38. Rosengren S, Wei N, Kalunian KC, Zvaifler NJ, Kavanaugh A, Boyle DL. Elevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab. Arthritis Res Ther (2008) 10(5):R105. doi:10.1186/ar2497
39. Winter O, Dame C, Jundt F, Hiepe F. Pathogenic long-lived plasma cells and their survival niches in autoimmunity, malignancy, and allergy. J Immunol (2012) 189(11):5105-11. doi:10.4049/jimmunol.1202317
40. Krumbholz M, Theil D, Cepok S, Hemmer B, Kivisakk P, Ransohoff RM, et al. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain (2006) 129(Pt 1):200-11. doi:10.1093/brain/awh680
41. Corcione A, Casazza S, Ferretti E, Giunti D, Zappia E, Pistorio A, et al. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc Natl Acad Sci U S A (2004) 101(30):11064-9. doi:10.1073/pnas.0402455101
42. Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain (2007) 130(Pt 4):1089-104. doi:10.1093/brain/awm038
43. Prineas JW, Wright RG. Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab Invest (1978) 38(4):409-21.
44. Harrer A, Tumani H, Niendorf S, Lauda F, Geis C, Weishaupt A, et al. Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy. Mult Scler (2013) 19(9):1209-12. doi:10.1177/1352458512463483
45. Butinx M, Moreels M, Vandenabeele F, Lambrichts I, Raus J, Steels P, et al. Cytokine-induced cell death in human oligodendroglial cell lines: I. Synergistic effects of IFNg and TNFa on apoptosis. J Neurosci Res (2004) 76:834-45. doi:10.1002/jnr.20118
46. Junker A, Ivanidze J, Malotka J, Eiglmeier I, Lassmann H, Wekerle H, et al. Multiple sclerosis: T-cell receptor expression in distinct brain regions. Brain (2007) 130(Pt 11):2789-99. doi:10.1093/brain/awm214
47. Harp C, Lee J, Lambracht-Washington D, Cameron E, Olsen G, Frohman E, et al. Cerebrospinal fluid B cells from multiple sclerosis patients are subject to normal germinal center selection. J Neuroimmunol (2007) 183(1-2):189-99. doi:10.1016/j.jneuroim.2006.10.020
48. Zhang Y, Da R-R, Guo W, Ren H-M, Hilgenberg LG, Sobel RA, et al. Axon reactive B cells clonally expanded in the cerebrospinal fluid of patients with multiple sclerosis. J Clin Immunol (2005) 25(3):254-64. doi:10.1007/s10875-005-4083-5
49. Jacobi C, Lange P, Reiber H. Quantitation of intrathecal antibodies in cerebrospinal fluid of subacute sclerosing panencephalitis, herpes simplex encephalitis and multiple sclerosis: discrimination between microorganism-driven and polyspecific immune response. J Neuroimmunol (2007) 187(1-2):139-46. doi:10.1016/j.jneuroim.2007.04.002
50. Conrad AJ, Chiang EY, Andeen LE, Avolio C, Walker SM, Baumhefner RW, et al. Quantitation of intrathecal measles virus IgG antibody synthesis rate: subacute sclerosing panencephalitis and multiple sclerosis. J Neuroimmunol (1994) 54(1-2):99-108. doi:10.1016/0165-5728(94)90236-4
51. Otto C, Hofmann J, Finke C, Zimmermann M, Ruprecht K. The fraction of varicella zoster virus-specific antibodies among all intrathecally-produced antibodies discriminates between patients with varicella zoster virus reactivation and multiple sclerosis. Fluids Barriers CNS (2014) 11(1):3. doi:10.1186/2045-8118-11-3
52. Otto C, Oltmann A, Stein A, Frenzel K, Schroeter J, Habbel P, et al. Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis. Neurology (2011) 76(15):1316-21. doi:10.1212/WNL.0b013e318215286d
53. Graef IT, Henze T, Reiber H. [Polyspecific immune reaction in the central nervous system in autoimmune diseases with CNS involvement]. Z Arztl Fortbild (Jena) (1994) 88(7-8):587-91.
54. Vrethem M, Ernerudh J, Lindstrom F, Skogh T. Immunoglobulins within the central nervous system in primary Sjogren's syndrome. J Neurol Sci (1990) 100(1-2):186-92. doi:10.1016/0022-510X(90)90032-I
55. Jarius S, Eichhorn P, Jacobi C, Wildemann B, Wick M, Voltz R. The intrathecal, polyspecific antiviral immune response: specific for MS or a general marker of CNS autoimmunity? J Neurol Sci (2009) 280(1-2):98-100. doi:10.1016/j.jns.2008.08.002
56. Nociti V, Frisullo G, Marti A, Luigetti M, Iorio R, Patanella AK, et al. Epstein-Barr virus antibodies in serum and cerebrospinal fluid from multiple sclerosis, chronic inflammatory demyelinating polyradiculoneuropathy and amyotrophic lateral sclerosis. J Neuroimmunol (2010) 225(1-2):149-52. doi:10.1016/j.jneuroim.2010.04.007
57. Puccioni-Sohler M, Kitze B, Felgenhauer K, Graef IT, Lange P, Novis S, et al. The value of CSF analysis for the differential diagnosis of HTLV-I associated myelopathy and multiple sclerosis. Arq Neuropsiquiatr (1995) 53(4):760-5. doi:10.1590/S0004-282X1995000500008
58. Reiber H, Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem (1991) 37(7):1153-60.
59. Puel J, Gayet C, Averous S, Brochier B. Synthèse intrathécale des anticorps viraux au cours des encéphalits virales. Med Mal Infect (1982) 10:616-9.
60. Felgenhauer K, Luer W, Poser S. Chronic HIV encephalitis. J Neuroimmunol (1988) 20(2-3):141-4. doi:10.1016/0165-5728(88)90145-2
61. Felgenhauer K, Reiber H. The diagnostic significance of antibody specificity indices in multiple sclerosis and herpes virus induced diseases of the nervous system. Clin Investig (1992) 70(1):28-37. doi:10.1007/BF00422934
62. Vandvik B, Skoldenberg B, Forsgren M, Stiernstedt G, Jeansson S, Norrby E. Long-term persistence of intrathecal virus-specific antibody responses after herpes simplex virus encephalitis. J Neurol (1985) 231(6):307-12. doi:10.1007/BF00313707
63. Riikonen R, Meurman O. Long-term persistence of intrathecal viral antibody responses in postinfectious diseases of the central nervous system and in Rett syndrome. Neuropediatrics (1989) 20(4):215-9. doi:10.1055/s-2008-1071296
64. Vandvik B, Vartdal F, Norrby E. Herpes simplex virus encephalitis: intrathecal synthesis of oligoclonal virus-specific IgG, IgA and IgM antibodies. J Neurol (1982) 228(1):25-38. doi:10.1007/BF00313407
65. Vandvik B, Nilsen RE, Vartdal F, Norrby E. Mumps meningitis: specific and non-specific antibody responses in the central nervous system. Acta Neurol Scand (1982) 65(5):468-87. doi:10.1111/j.1600-0404.1982.tb03104.x
66. Kaiser R. Variable CSF findings in early and late Lyme neuroborreliosis: a follow-up study in 47 patients. J Neurol (1994) 242(1):26-36. doi:10.1007/BF00920571
67. Chattopadhyay S, Ito M, Cooper JD, Brooks AI, Curran TM, Powers JM, et al. An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Hum Mol Genet (2002) 11(12):1421-31. doi:10.1093/hmg/11.12.1421
68. Korenke GC, Reiber H, Hunneman DH, Hanefeld F. Intrathecal IgA synthesis in X-linked cerebral adrenoleukodystrophy. J Child Neurol (1997) 12(5):314-20. doi:10.1177/088307389701200505
69. Lowhagen GB, Andersson M, Blomstrand C, Roupe G. Central nervous system involvement in early syphilis. Part 1. Intrathecal immunoglobulin production. Acta Derm Venereol (1983) 63(5):409-17.
70. Lisak RP, Benjamins JA, Nedelkoska L, Barger JL, Ragheb S, Fan B, et al. Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro. J Neuroimmunol (2012) 246(1-2):85-95. doi:10.1016/j.jneuroim.2012.02.015
71. Steelman AJ, Li J. Poly(I:C) promotes TNFalpha/TNFR1-dependent oligodendrocyte death in mixed glial cultures. J Neuroinflammation (2011) 8:89. doi:10.1186/1742-2094-8-89
72. Reiber H, Teut M, Pohl D, Rostasy KM, Hanefeld F. Paediatric and adult multiple sclerosis: age-related differences and time course of the neuroimmunological response in cerebrospinal fluid. Mult Scler (2009) 15(12):1466-80. doi:10.1177/1352458509348418
73. Willis SN, Stadelmann C, Rodig SJ, Caron T, Gattenloehner S, Mallozzi SS, et al. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain (2009) 132(Pt 12):3318-28. doi:10.1093/brain/awp200
74. Aloisi F, Serafini B, Magliozzi R, Howell OW, Reynolds R. Detection of Epstein-Barr virus and B-cell follicles in the multiple sclerosis brain: what you find depends on how and where you look. Brain (2010) 133(Pt 12):e157. doi:10.1093/brain/awq223
75. Bray PF, Luka J, Bray PF, Culp KW, Schlight JP. Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein. Neurology (1992) 42(9):1798-804. doi:10.1212/WNL.42.9.1798
76. Jafari N, van Nierop GP, Verjans GM, Osterhaus AD, Middeldorp JM, Hintzen RQ. No evidence for intrathecal IgG synthesis to Epstein Barr virus nuclear antigen-1 in multiple sclerosis. J Clin Virol (2010) 49(1):26-31. doi:10.1016/j.jcv.2010.06.007
77. Castellazzi M, Tamborino C, Cani A, Negri E, Baldi E, Seraceni S, et al. Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis. Mult Scler (2010) 16(7):883-7. doi:10.1177/1352458510368051
78. Villegas E, Santiago O, Carrillo JA, Sorlozano A, Guerrero M, Fernandez O, et al. Low intrathecal immune response of anti-EBNA-1 antibodies and EBV DNA from multiple sclerosis patients. Diagn Microbiol Infect Dis (2011) 70(1):85-90. doi:10.1016/j.diagmicrobio.2010.11.013
79. Sargsyan SA, Shearer AJ, Ritchie AM, Burgoon MP, Anderson S, Hemmer B, et al. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology (2010) 74(14):1127-35. doi:10.1212/WNL.0b013e3181d865a1
80. Pohl D, Rostasy K, Jacobi C, Lange P, Nau R, Krone B, et al. Intrathecal antibody production against Epstein-Barr and other neurotropic viruses in pediatric and adult onset multiple sclerosis. J Neurol (2010) 257(2):212-6. doi:10.1007/s00415-009-5296-y
81. Magliozzi R, Serafini B, Rosicarelli B, Chiappetta G, Veroni C, Reynolds R, et al. B-cell enrichment and Epstein-Barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis. J Neuropathol Exp Neurol (2013) 72(1):29-41. doi:10.1097/NEN.0b013e31827bfc62
82. Jaquiery E, Jilek S, Schluep M, Meylan P, Lysandropoulos A, Pantaleo G, et al. Intrathecal immune responses to EBV in early MS. Eur J Immunol (2010) 40(3):878-87. doi:10.1002/eji.200939761
83. Lucchinetti CF, Popescu BF, Bunyan RF, Moll NM, Roemer SF, Lassmann H, et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med (2011) 365(23):2188-97. doi:10.1056/NEJMoa1100648
84. von Budingen HC, Bar-Or A, Zamvil SS. B cells in multiple sclerosis: connecting the dots. Curr Opin Immunol (2011) 23(6):713-20. doi:10.1016/j.coi.2011.09.003
85. Kuerten S, Schickel A, Kerkloh C, Recks MS, Addicks K, Ruddle NH, et al. Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response. Acta Neuropathol (2012) 124(6):861-73. doi:10.1007/s00401-012-1023-3
86. Lovato L, Willis SN, Rodig SJ, Caron T, Almendinger SE, Howell OW, et al. Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis. Brain (2011) 134(Pt 2):534-41. doi:10.1093/brain/awq350
87. Skorstad G, Vandvik B, Vartdal F, Holmoy T. MS and clinically isolated syndromes: shared specificity but diverging clonal patterns of virus-specific IgG antibodies produced in vivo and by CSF B cells in vitro. Eur J Neurol (2009) 16(10):1124-9. doi:10.1111/j.1468-1331.2009.02657.x
88. Owens GP, Winges KM, Ritchie AM, Edwards S, Burgoon MP, Lehnhoff L, et al. VH4 gene segments dominate the intrathecal humoral immune response in multiple sclerosis. J Immunol (2007) 179(9):6343-51.
89. Colombo M, Dono M, Gazzola P, Roncella S, Valetto A, Chiorazzi N, et al. Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients. J Immunol (2000) 164(5):2782-9.
90. von Budingen HC, Kuo TC, Sirota M, van Belle CJ, Apeltsin L, Glanville J, et al. B cell exchange across the blood-brain barrier in multiple sclerosis. J Clin Invest (2012) 122(12):4533-43. doi:10.1172/JCI63842
91. Meinl E, Krumbholz M, Hohlfeld R. B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation. Ann Neurol (2006) 59(6):880-92. doi:10.1002/ana.20890
92. Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med (2004) 350(25):2572-81. doi:10.1056/NEJMoa032534
93. Bielekova B, Herman ML. Method of treating multiple sclerosis by intrathecal depletion of B cells and biomarkers to select patients with progressive multiple sclerosis. Google Patents (2013). Patent No. WO2013049362.